How to Sell a Podiatry Practice
Learn how to sell a podiatry practice: how procedures and ancillaries drive value, emerging PE buyers, preparation, and running a competitive sale.
In this article
- Why podiatry is attracting investment
- What drives the value of a podiatry practice
- Who buys podiatry practices?
- How to prepare your podiatry practice for sale
- How Tenet M&A helps you sell a podiatry practice
- Podiatry practices for sale: an emerging buyer market
- Frequently asked questions about selling a podiatry practice
Podiatry practices sell for a multiple of Adjusted EBITDA, with in-office procedures, imaging, DME, and wound care driving value. Emerging podiatry-focused PE platforms are consolidating the space, and associate coverage strongly affects where a practice lands. See typical ranges in our valuation multiples by specialty guide.
Podiatry is an emerging frontier in healthcare consolidation. An aging, increasingly diabetic population, strong in-office procedure volume, and valuable ancillaries have begun to draw private-equity platforms and larger groups into the specialty. For podiatrists who own their practice, getting ahead of that wave can mean a strong exit — if you understand what buyers value and run a disciplined process. This page explains how to sell a podiatry practice and how Tenet M&A helps you maximize value.
Tenet M&A advises podiatrists on confidential sales, partnerships, and transitions. When you are ready, we help you sell your podiatry practice the right way. For the full process, see our complete guide to selling a practice.
Why podiatry is attracting investment
Podiatry pairs recurring chronic care — particularly diabetic foot care and wound management — with high-volume in-office procedures and surgery. Ancillaries such as imaging, DME, orthotics, and physical therapy add further revenue. Favorable demographics and a fragmented ownership base have started to attract consolidators, positioning well-run practices for competitive interest as the trend accelerates.
What drives the value of a podiatry practice
- In-office procedures and surgery. Strong procedural volume signals durable earnings.
- Ancillaries. Imaging, DME, orthotics, and PT add high-margin revenue.
- Recurring chronic care. Diabetic and wound-care patient bases provide predictable demand.
- Provider depth. Multiple podiatrists and advanced-practice providers reduce owner dependence.
- Growth and geography. Expansion runway and a desirable market increase appeal.
See our medical practice valuation guide and what buyers value most.
Wondering how this applies to your practice? A Tenet advisor can walk you through it in a confidential call.
Talk to an advisorWho buys podiatry practices?
Podiatry sellers may hear from emerging PE-backed platforms, larger podiatry and MSK groups, and individual physicians. As consolidation grows, platform buyers increasingly offer premium multiples for practices with strong ancillaries and reduced owner dependence, often with equity rollover and a continued role. Weigh the trade-offs in selling to private buyers vs. MSOs or platforms.
How to prepare your podiatry practice for sale
Prepare 12 to 36 months ahead. Document procedural and ancillary revenue, strengthen provider depth, keep clean financials with a clear add-back schedule, secure referral relationships, and resolve compliance and coding issues before diligence. These steps directly influence value — see how to prepare your practice for sale.
How Tenet M&A helps you sell a podiatry practice
Tenet M&A runs a confidential, competitive process built for podiatry — a healthcare-specific valuation that captures ancillary value, careful preparation, access to platform and independent buyers, and skilled negotiation of price and terms. Explore our advisory services or start a confidential conversation. This page is educational and not tax or legal advice.
Podiatry practices for sale: an emerging buyer market
Podiatry is earlier in its consolidation cycle than most specialties, which cuts both ways. A podiatry practice valuation still rewards the familiar drivers — in-office procedures, imaging, DME and wound care — but the buyer pool is thinner, so what a podiatry practice for sale actually fetches depends more than usual on reaching the right acquirer rather than any acquirer.
That is precisely the situation where representation matters most. A podiatry practice broker or M&A advisor who tracks the platforms beginning to assemble podiatry groups can create competition in a market where an owner acting alone may only ever meet one buyer.
See how your specialty compares in our valuation multiples by specialty guide, explore how we represent sellers, or start a confidential conversation.
Frequently asked questions about selling a podiatry practice
How much is my podiatry practice worth?
Podiatry practices are valued on a multiple of Adjusted EBITDA, with in-office procedures, ancillaries (imaging, DME, orthotics, PT), recurring chronic care, and provider depth driving the multiple. Ancillary-rich practices can command stronger values.
Is private equity buying podiatry practices?
Increasingly, yes. Favorable demographics, recurring chronic-care demand, and a fragmented market have begun drawing PE-backed platforms and larger groups into podiatry consolidation.
Do ancillaries increase my podiatry practice’s value?
Typically yes. Imaging, DME, orthotics, and PT add high-margin revenue that buyers value, raising a podiatry practice’s worth.
How long does it take to sell a podiatry practice?
Most sales take about eight to sixteen months from preparation to closing. Starting early lets you strengthen ancillaries and run a competitive process.
Is there a market for podiatry practices?
Yes, though it is less consolidated than specialties such as dermatology or ophthalmology. Platforms are beginning to assemble podiatry groups, and individual podiatrists remain active buyers. Because the buyer pool is thinner, reaching the right acquirer matters more than in heavily consolidated specialties.
Planning a sale or transition?
Talk through timing, structure and likely buyers in a confidential conversation with a Tenet advisor.

